XML 58 R49.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2026
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 10 months 24 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 5,225,103
Number of grants, issued | shares 2,867,530
Number of grants, exercised | shares (213,582)
Number of grants, cancelled/forfeited | shares (118,856)
Number of units, grant outstanding ending balance | shares 7,760,195
Number of grants, vested | shares 3,648,546
Number of grants, unvested | shares 4,111,649
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 14.52
Weighted average exercise price, grants exercised | $ / shares 13.45
Weighted average exercise price, grants issued | $ / shares 12.19
Weighted average exercise price, cancelled/forfeited | $ / shares 12.55
Weighted average exercise price, grant outstanding ending balance | $ / shares 13.72
Weighted average exercise price, grants vested | $ / shares 13.97
Weighted average exercise price, grants unvested | $ / shares $ 13.49
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years 6 months
Weighted Average Remaining Contractual Term, Grants Vested 5 years 7 months 6 days
Aggregate Intrinsic Value, grants outstanding | $ $ 33.9
Aggregate Intrinsic Value, grants vested | $ $ 14.9
First Advantage Corporation [Member] | 2020 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,275,393
Number of grants, exercised | shares (60,601)
Number of units, grant outstanding ending balance | shares 1,214,792
Number of grants, vested | shares 1,099,547
Number of grants, unvested | shares 115,245
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants exercised | $ / shares 5.11
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.14
Weighted average exercise price, grants unvested | $ / shares $ 5.23
Weighted Average Remaining Contractual Term, Grants Outstanding 3 years 8 months 12 days
Weighted Average Remaining Contractual Term, Grants Vested 3 years 7 months 6 days
Aggregate Intrinsic Value, grants outstanding | $ $ 15.7
Aggregate Intrinsic Value, grants vested | $ $ 14.2